{"id":21417,"date":"2026-03-03T08:00:33","date_gmt":"2026-03-03T13:00:33","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?p=21417"},"modified":"2026-03-03T07:09:53","modified_gmt":"2026-03-03T12:09:53","slug":"prfandforge","status":"publish","type":"post","link":"https:\/\/www.progeriaresearch.org\/es\/2026\/03\/03\/prfandforge\/","title":{"rendered":"\u00a1PRF anuncia una asociaci\u00f3n de fabricaci\u00f3n con Forge Biologics para avanzar en la terapia g\u00e9nica contra la progeria!"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-74px|auto||auto|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Pttc&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20802 aligncenter\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2025\/08\/PTCP_wPRF-1024x511.jpg\" alt=\"\" width=\"491\" height=\"245\" \/><\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Sam-Pro 2&#8243; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>PRF ha firmado un acuerdo de fabricaci\u00f3n con\u00a0<a href=\"https:\/\/www.forgebiologics.com\/\">Productos biol\u00f3gicos Forge\u00a0<\/a>producir\u00a0<strong>SamPro-2<\/strong> \u2013 Terapia de edici\u00f3n gen\u00e9tica en investigaci\u00f3n de PRF dise\u00f1ada para corregir la mutaci\u00f3n gen\u00e9tica que causa la progeria.<\/p>\n<p>Este es un paso decisivo hacia los ensayos cl\u00ednicos de terapia g\u00e9nica para la progeria.<\/p>\n<h4><strong>\u00bfQu\u00e9 es SamPro-2?<\/strong><\/h4>\n<p><strong><\/strong>SamPro-2 es la terapia de edici\u00f3n gen\u00e9tica de PRF dise\u00f1ada para corregir la falta de ortograf\u00eda de una sola letra del ADN que causa la progeria.<\/p>\n<p>El ADN es el manual de instrucciones del cuerpo. En ni\u00f1os y adultos j\u00f3venes con progeria, solo una letra de ese manual es incorrecta: hay una &quot;T&quot; que deber\u00eda ser una &quot;C&quot;. Ese cambio en una sola letra provoca la producci\u00f3n de una prote\u00edna t\u00f3xica llamada progerina, causante de la enfermedad.<\/p>\n<p>SamPro-2 est\u00e1 dise\u00f1ado para corregir ese error (cambiando permanentemente la \u201cT\u201d por una \u201cC\u201d) con el objetivo de detener la enfermedad dentro de las c\u00e9lulas del cuerpo en su origen.<\/p>\n<p>[\/et_pb_text][et_pb_testimonial quote_icon_color=&#8221;#FFFFFF&#8221; quote_icon_background_color=&#8221;#8FD2ED&#8221; admin_label=&#8221;Leslie Quote&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;65%&#8221; module_alignment=&#8221;center&#8221; min_height=&#8221;83px&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;1px||12px||false|false&#8221; border_radii=&#8221;on|35px|35px|35px|35px&#8221; border_width_all=&#8221;5px&#8221; border_color_all=&#8221;#00B2E2&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>&quot;<em>Ha llegado la era de la terapia g\u00e9nica para la progeria. Esperamos que SamPro-2 brinde a los ni\u00f1os y j\u00f3venes con progeria la vida m\u00e1s larga y saludable que merecen. Estamos sumamente agradecidos de trabajar con Forge Biologics, cuya experiencia en fabricaci\u00f3n es esencial para que este trabajo avance del laboratorio a los ensayos cl\u00ednicos.<\/em>.\u201d<\/p>\n<p>~Leslie Gordon, MD, Ph.D., cofundadora y directora m\u00e9dica de PRF y madre de Sam Berns, quien tuvo progeria<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-28 aligncenter\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/04\/PRF_Logo_2019_4color.png\" alt=\"\" width=\"333\" height=\"95\" srcset=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/04\/PRF_Logo_2019_4color.png 595w, https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/04\/PRF_Logo_2019_4color-300x86.png 300w\" sizes=\"(max-width: 333px) 100vw, 333px\" \/><\/p>\n<p>\u200b<\/p>\n<p>[\/et_pb_testimonial][et_pb_text admin_label=&#8221;PRF chose Forge&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><strong>\u00bfPor qu\u00e9 PRF eligi\u00f3 a Forge para fabricar SamPro-2?<\/strong><\/h4>\n<p>Antes de que se pueda administrar cualquier terapia gen\u00e9tica a una persona, es necesario:<\/p>\n<ul>\n<li>Fabricado en instalaciones ultralimpias y altamente especializadas.<\/li>\n<li>Producido bajo estrictos est\u00e1ndares actuales de Buenas Pr\u00e1cticas de Manufactura (cGMP)<\/li>\n<li>Probado repetidamente para garantizar su seguridad, pureza y consistencia.<\/li>\n<li>Preparado para la revisi\u00f3n regulatoria de la FDA de EE. UU.<\/li>\n<\/ul>\n<p>Forge Biologics es l\u00edder en la fabricaci\u00f3n de terapia g\u00e9nica. Su experiencia nos ayudar\u00e1 a llevar SamPro-2 de la ciencia de laboratorio innovadora a ensayos cl\u00ednicos para ni\u00f1os y adultos j\u00f3venes con progeria.<\/p>\n<p>La fabricaci\u00f3n es el puente entre el descubrimiento y el tratamiento.<\/p>\n<p>Esta asociaci\u00f3n construye ese puente.<\/p>\n<p>[\/et_pb_text][et_pb_testimonial quote_icon_color=&#8221;#FFFFFF&#8221; quote_icon_background_color=&#8221;#8FD2ED&#8221; admin_label=&#8221;Forge Quote&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;65%&#8221; module_alignment=&#8221;center&#8221; min_height=&#8221;83px&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;1px||12px||false|false&#8221; border_radii=&#8221;on|35px|35px|35px|35px&#8221; border_width_all=&#8221;5px&#8221; border_color_all=&#8221;#00B2E2&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>&quot;<em>Detr\u00e1s de cada programa como este hay pacientes y familias que han esperado mucho tiempo para ver avances. La Fundaci\u00f3n para la Investigaci\u00f3n de la Progeria y su Equipo Gen\u00e9tico han demostrado una dedicaci\u00f3n extraordinaria al avance de esta ciencia, y nos honra colaborar con ellos. En Forge, aportamos ese mismo nivel de atenci\u00f3n, experiencia y rigor t\u00e9cnico a nuestra labor de fabricaci\u00f3n mientras contribuimos al avance de este programa para los pacientes.\u201d<\/em><\/p>\n<p>~John Maslowski, presidente y director ejecutivo de Forge Biologics<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-21424 aligncenter\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/Forge-Logo-1024x511.png\" alt=\"\" width=\"271\" height=\"135\" \/><\/p>\n<p>\u200b<\/p>\n<p>[\/et_pb_testimonial][et_pb_text admin_label=&#8221;Progeria Gene Dream Team&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><strong>El equipo de genes de la progeria<\/strong><\/h4>\n<p>PRF y sus colaboradores, conocidos colectivamente como el Equipo Gen\u00e9tico de Progeria, crearon SamPro-2. El Equipo Gen\u00e9tico de Progeria re\u00fane a l\u00edderes reconocidos internacionalmente en gen\u00e9tica, medicina cl\u00ednica e innovaci\u00f3n biom\u00e9dica, todos impulsados por el compromiso compartido de encontrar la cura para la progeria.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-21425 aligncenter\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/GeneTeamforge-page-1024x414.jpg\" alt=\"\" width=\"734\" height=\"297\" \/><\/p>\n<p><strong>Dr. Francis S. Collins, doctor en medicina<\/strong><br \/>Asesor principal de investigaci\u00f3n de PRF y ex director de los Institutos Nacionales de Salud, que dirigi\u00f3 el Proyecto Genoma Humano, uno de los logros cient\u00edficos m\u00e1s importantes de nuestro tiempo, y ayud\u00f3 a llevar la gen\u00e9tica a la era moderna.<\/p>\n<p><strong>Dra. Leslie Gordon, doctora en medicina<\/strong><br \/>Cofundadora y directora m\u00e9dica de PRF; la principal experta mundial en progeria y una fuerza impulsora de cada gran avance en este campo. La Dra. Gordon tambi\u00e9n es madre de Sam, cuya vida inspir\u00f3 la creaci\u00f3n de PRF y contin\u00faa impulsando su urgencia.<\/p>\n<p><strong>Dr. David R. Liu<\/strong><br \/>Profesor Richard Merkin y director del Instituto Merkin de Tecnolog\u00edas Transformativas en la Salud del Instituto Broad del MIT y Harvard. El Dr. Liu es un pionero mundialmente reconocido en edici\u00f3n gen\u00e9tica y un l\u00edder internacional en el desarrollo de tecnolog\u00edas de edici\u00f3n de bases que est\u00e1n transformando la medicina moderna.<\/p>\n<p><strong>El difunto Sammy Basso, MS<\/strong><br \/>Cient\u00edfico, defensor y miembro extraordinario de la comunidad global de progeria. La inteligencia, la valent\u00eda y el compromiso inquebrantable de Sammy con el avance de la investigaci\u00f3n siguen inspirando y guiando este trabajo. Sammy fue embajador internacional de PRF. Sammy y su familia crearon la Asociaci\u00f3n Italiana de Progeria Sammy Basso (AIPro.Sa.B.) para ayudar a encontrar la cura de la progeria.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;why turning point&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><strong>Por qu\u00e9 este es un punto de inflexi\u00f3n<\/strong><\/h4>\n<p>Para las familias, este es un impulso tangible.<\/p>\n<p>Para los donantes, este es el impacto de su inversi\u00f3n en ciencia audaz.<\/p>\n<p>Para la comunidad m\u00e1s amplia de enfermedades raras, esto representa uno de los esfuerzos m\u00e1s avanzados hasta el momento para corregir una enfermedad multisist\u00e9mica, pedi\u00e1trica y mortal en su origen gen\u00e9tico.<\/p>\n<p>A\u00fan tenemos trabajo importante por delante. Pero este es un gran paso adelante. Y cada paso nos acerca a nuestra visi\u00f3n: <strong>Un mundo donde cada ni\u00f1o con progeria se cure.<\/strong><\/p>\n<p><a href=\"https:\/\/www.progeriaresearch.org\/es\/press-room\/\"><strong>Lea el comunicado de prensa aqu\u00ed<\/strong><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a1PRF anuncia una asociaci\u00f3n de fabricaci\u00f3n con Forge Biologics para avanzar en la terapia g\u00e9nica contra la progeria!<br \/>\nEste anuncio marca un hito importante: PRF ha firmado un acuerdo de fabricaci\u00f3n con Forge Biologics para producir SamPro-2, su terapia de edici\u00f3n gen\u00e9tica en desarrollo para ni\u00f1os y adultos j\u00f3venes con progeria, \u00a1un paso esencial hacia los ensayos cl\u00ednicos y, en \u00faltima instancia, la cura! <\/p>","protected":false},"author":2,"featured_media":21431,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[11,2,1],"tags":[],"class_list":["post-21417","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-homepage-news","category-news","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PRF Partnership with Forge I The Progeria Research Foundation<\/title>\n<meta name=\"description\" content=\"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.progeriaresearch.org\/es\/2026\/03\/03\/prfandforge\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PRF Partnership with Forge I The Progeria Research Foundation\" \/>\n<meta property=\"og:description\" content=\"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.progeriaresearch.org\/es\/2026\/03\/03\/prfandforge\/\" \/>\n<meta property=\"og:site_name\" content=\"The Progeria Research Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ProgeriaResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-03T13:00:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karen Betournay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Progeria\" \/>\n<meta name=\"twitter:site\" content=\"@Progeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karen Betournay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/\"},\"author\":{\"name\":\"Karen Betournay\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\"},\"headline\":\"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!\",\"datePublished\":\"2026-03-03T13:00:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/\"},\"wordCount\":1004,\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg\",\"articleSection\":[\"Homepage News\",\"News\",\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/\",\"name\":\"PRF Partnership with Forge I The Progeria Research Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg\",\"datePublished\":\"2026-03-03T13:00:33+00:00\",\"description\":\"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!\",\"breadcrumb\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg\",\"width\":1000,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.progeriaresearch.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"name\":\"The Progeria Research Foundation\",\"description\":\"For the Children \u2665 For the Cure\",\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\",\"name\":\"The Progeria Research Foundation\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"width\":300,\"height\":86,\"caption\":\"The Progeria Research Foundation\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ProgeriaResearch\/\",\"https:\/\/x.com\/Progeria\",\"https:\/\/www.instagram.com\/progeriaresearch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\",\"name\":\"Karen Betournay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"caption\":\"Karen Betournay\"},\"url\":\"https:\/\/www.progeriaresearch.org\/es\/author\/karenb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRF Partnership with Forge I The Progeria Research Foundation","description":"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.progeriaresearch.org\/es\/2026\/03\/03\/prfandforge\/","og_locale":"es_ES","og_type":"article","og_title":"PRF Partnership with Forge I The Progeria Research Foundation","og_description":"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!","og_url":"https:\/\/www.progeriaresearch.org\/es\/2026\/03\/03\/prfandforge\/","og_site_name":"The Progeria Research Foundation","article_publisher":"https:\/\/www.facebook.com\/ProgeriaResearch\/","article_published_time":"2026-03-03T13:00:33+00:00","og_image":[{"width":1000,"height":1000,"url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg","type":"image\/jpeg"}],"author":"Karen Betournay","twitter_card":"summary_large_image","twitter_creator":"@Progeria","twitter_site":"@Progeria","twitter_misc":{"Written by":"Karen Betournay","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#article","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/"},"author":{"name":"Karen Betournay","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946"},"headline":"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!","datePublished":"2026-03-03T13:00:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/"},"wordCount":1004,"publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg","articleSection":["Homepage News","News","Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/","url":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/","name":"PRF Partnership with Forge I The Progeria Research Foundation","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg","datePublished":"2026-03-03T13:00:33+00:00","description":"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy! This announcement marks a major milestone: PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2, its gene editing therapy in development for children and young adults with Progeria -- an essential step toward clinical trials and, ultimately, the cure!","breadcrumb":{"@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#primaryimage","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2026\/03\/PtTCwprf.jpg","width":1000,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/www.progeriaresearch.org\/2026\/03\/03\/prfandforge\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.progeriaresearch.org\/"},{"@type":"ListItem","position":2,"name":"PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!"}]},{"@type":"WebSite","@id":"https:\/\/www.progeriaresearch.org\/ta\/#website","url":"https:\/\/www.progeriaresearch.org\/ta\/","name":"La Fundaci\u00f3n para la Investigaci\u00f3n de la Progeria","description":"Por los ni\u00f1os \u2665 Por la cura","publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization","name":"La Fundaci\u00f3n para la Investigaci\u00f3n de la Progeria","url":"https:\/\/www.progeriaresearch.org\/ta\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","width":300,"height":86,"caption":"The Progeria Research Foundation"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ProgeriaResearch\/","https:\/\/x.com\/Progeria","https:\/\/www.instagram.com\/progeriaresearch\/"]},{"@type":"Person","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946","name":"Karen Betournay","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","caption":"Karen Betournay"},"url":"https:\/\/www.progeriaresearch.org\/es\/author\/karenb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/posts\/21417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/comments?post=21417"}],"version-history":[{"count":0,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/posts\/21417\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/media\/21431"}],"wp:attachment":[{"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/media?parent=21417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/categories?post=21417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/es\/wp-json\/wp\/v2\/tags?post=21417"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}